How Covered Entities and Pharma Companies Can Better Collaborate on Drug Discount Programs
Three things drug manufacturers and CEs can do to build trust and enable effective collaboration
The Potential for AI in Drug Design
Despite misconceptions about its use, artificial intelligence (AI), through modalities such as machine learning models, is poised to enable companies to expedite the drug design process.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
The supply chain crisis is spurring companies to transform production and sourcing strategies to reduce risk
The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.
The supply chain crisis is spurring companies to transform production and sourcing strategies to reduce risk
The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.
Like it or not, value-based contracting is coming for drugs and medical devices
Value-based contracts covering the reimbursement of drugs and medical devices are slowly gaining acceptance. A panel at the MedCity News INVEST conference discussed the challenges and opportunities for these contracts, which aim to improve patient outcomes and control the cost of care.
New Alexa feature lets users ask about medications
A new partnership between Amazon and First Databank will let users ask Alexa for basic information about the most commonly prescribed drugs.
Unlocking Transparency in PBM Pricing
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Will Proteus’ pivot pay off?
Proteus, which makes tiny sensors that can track medication adherence, will no longer develop the technology in behavioral health medications for Otsuka Pharmaceutical. Instead, the startup is shifting its focus to oncology and infectious diseases, where it hopes its tech will have better traction.
Does HHS have zero negotiating power in drug pricing?
Through the 340B program, the government is able to negotiate drug pricing for patients seeking care in certain covered entities and the savings from this program should be passed on to consumers.
Why does the cost of prescription drugs keep rising?
The pharmaceutical industry has introduced extraordinary health-care advances but if we don’t get a handle on the perverse incentives operating throughout the system, we may be pricing ourselves and our economy into oblivion.
MedCity News launches biopharma-focused newsletter
The biotech century has arrived, and it's consequently now more important than ever for us to highlight our coverage of biopharma.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Biopharma startup financing had strong showing in 2018, report shows
The report, by PitchBook, shows figures consistent with a similar report earlier this month by Silicon Valley Bank, which forecast more M&A deals this year.
presented by
Bristol-Myers Squibb to acquire Celgene in $74B deal
The acquisition brings together two of the largest drugmakers in the country, both of which are major players in biopharma, particularly oncology.
Blockchain becomes a ‘source of truth’ for biopharma
Although blockchain faces regulatory hurdles and skepticism, its potential as a shared, yet secure ledger system to improve the pharmaceutical supply chain integrity and clinical trials is making it attractive for experimentation and investment by drugmakers.
How Besse Medical is innovating in inventory management
The company, which is a distributor of pharmaceuticals and a division of AmerisourceBergen, offers two inventory management systems: CubixxMD and PODIS Plus.
TraceLink raises $93 million in Series D financing round
The company's life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.